Phencyclidine withdrawal disrupts episodic-like memory in rats: Reversal by donepezil but not clozapine

International Journal of Neuropsychopharmacology

Volumn 13, Issue 8, 2010, Pages 1011-1020

  Le Cozannet, Romain ^a   Fone, Kevin C F ^a   Moran, Paula M ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Antipsychotic; donepezil; episodic memory; object recognition; phencyclidine (PCP); schizophrenia

Indexed keywords

CLOZAPINE; DONEPEZIL; PHENCYCLIDINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISCRIMINATION LEARNING; EPISODIC MEMORY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECOGNITION; SPATIAL MEMORY; TASK PERFORMANCE;

ANIMALS; CLOZAPINE; INDANS; MALE; MEMORY DISORDERS; MEMORY, EPISODIC; PHENCYCLIDINE; PIPERIDINES; RATS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 77957232749     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145710000234     Document Type: Article

References (62)

1. Abdul-Monim Z, Neill JC, Reynolds GP (2007). Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat. Journal of Psychopharmacology 21,198-205. (Pubitemid 46280471)
2. Al-Uzri MM, Reveley MA, Owen L, Bruce J, et al. (2006). Measuring memory impairment in community-based patients with schizophrenia. Case-control study. British Journal of Psychiatry 189, 132-136. (Pubitemid 44231271)
3. Barker GR, Bird F, Alexander V, Warburton EC (2007). Recognition memory for objects, place, and temporal order: a disconnection analysis of the role of the medial prefrontal cortex and perirhinal cortex. Journal of Neuroscience 27, 2948-2957. (Pubitemid 46438982)
4. Beracochea D, Philippin J, Meunier S, Morain P, et al. (2007). Improvement of episodic contextual memory by S 18986 in middle-aged mice: comparison with donepezil. Psychopharmacology 193, 63-73. (Pubitemid 46906630)
5. Beraki S, Diaz-Heijtz R, Tai F, Ogren SO (2009). Effects of repeated treatment of phencyclidine on cognition and gene expression in C57BL/6 mice. International Journal of Neuropsychopharmacology 12, 243-255.
6. Berenbaum H, Kerns JG, Vernon LL, Gomez JJ (2008). Cognitive correlates of schizophrenia signs and symptoms: III. Hallucinations and delusions. Psychiatry Research 159, 163-166.
7. Buchanan RW, Summerfelt A, Tek C, Gold J (2003). An open-labeled trial of adjunctive donepezil for cognitive impairments in patients with schizophrenia. Schizophrenia Research 59, 29-33. (Pubitemid 35284490)
8. Bullock R, Dengiz A (2005). Cognitive performance in patients with Alzheimer's disease receiving cholinesterase inhibitors for up to 5 years. International Journal of Clinical Practice 59, 817-822. (Pubitemid 43904548)
9. Chung YC, Lee CR, Park TW, Yang KH, et al. (2009). Effect of donepezil added to atypical antipsychotics on cognition in patients with schizophrenia: an open-label trial. World Journal of Biological Psychiatry 10, 156-162.
10. Clayton NS, Dickinson A (1998). Episodic-like memory during cache recovery by scrub jays. Nature 395, 272-274. (Pubitemid 28447550)
11. Crook JM, Tomaskovic-Crook E, Copolov DL, Dean B (2001). Low muscarinic receptor binding in prefrontal cortex from subjects with schizophrenia: a study of Brodmann's areas 8, 9, 10, and 46 and the effects of neuroleptic drug treatment. American Journal ofPsychiatry 158, 918-925. (Pubitemid 32547622)
12. Csernansky JG, Martin M, Shah R, Bertchume A, et al. (2005). Cholinesterase inhibitors ameliorate behavioral deficits induced by MK-801 in mice. Neuropsychopharmacology 30, 2135-2143. (Pubitemid 41643964)
13. Dere E, Huston JP, De Souza Silva MA (2005a). Episodic-like memory in mice: simultaneous assessment of object, place and temporal order memory. Brain Research Protocols 16, 10-19. (Pubitemid 41774066)
14. Dere E, Huston JP, De Souza Silva MA (2005 b). Integrated memory for objects, places, and temporal order: evidence for episodic-like memory in mice. Neurobiology of Learning and Memory 84, 214-221. (Pubitemid 41457377)
15. Dere E, Huston JP, De Souza Silva MA (2007). The pharmacology, neuroanatomy and neurogenetics of one-trial object recognition in rodents. Neuroscience & Biobehavioral Reviews 31, 673-704. (Pubitemid 46670336)
16. Eacott MJ, Norman G (2004). Integrated memory for object, place, and context in rats: a possible model of episodic-like memory? Journal of Neuroscience 24,1948-1953. (Pubitemid 38292807)
17. Eichenbaum H (2003). The hippocampus, episodic memory, declarative memory, spatial memory ... where does it all come together? International Congress Series 1250, 235-244.
18. Ennaceur A, Delacour J (1988). A new one-trial test for neurobiological studies of memory in rats. 1: behavioral data. Behavioural Brain Research 31, 47-59.
19. Enomoto T, Noda Y, Nabeshima T (2007). Phencyclidine and genetic animal models of schizophrenia developed in relation to the glutamate hypothesis. Methods & Findings in Experimental & Clinical Pharmacology 29, 291-301. (Pubitemid 47204052)
20. Freedman R, Hall M, Adler LE, Leonard S (1995). Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia. Biological Psychiatry 38, 22-33.
21. Friedman J, Adler DN, Howanitz E, Harvey PD, et al. (2002). A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia. Biological Psychiatry 51, 349-357. (Pubitemid 34251171)
22. Gold JM, Weinberger DR (1995). Cognitive deficits and the neurobiology of schizophrenia. Current Opinion Neurobiology 5, 225-230.
23. Goldberg TE, Greenberg RD, Griffin SJ, Gold JM, et al. (1993). The effect of clozapine on cognition and psychiatric symptoms in patients with schizophrenia. British Journal of Psychiatry 162, 43-48.
24. Good MA, Hale G, Staal V (2007). Impaired 'episodic-like' object memory in adult APPswe transgenic mice. Behavioural Neuroscience 121, 443-448.
25. Gopal YV, Variend H (2005). First-episode schizophrenia: review of cognitive deficits and cognitive remediation. Advances Psychiatric Treatment 11, 38-44. (Pubitemid 40081379)
26. Grayson B, Idris NF, Neill JC (2007). Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat. Behavioural Brain Research 184, 31-38. (Pubitemid 47404650)
27. Green MF, Kern RS, Heaton RK (2004). Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophrenia Research 72, 41-51.
28. Gron G, Kirstein M, Thielscher A, Riepe M, et al. (2005). Cholinergic enhancement of episodic memory in healthy young adults. Psychopharmacology 182, 170-179. (Pubitemid 41400874)
29. Harvey PD, Keefe RSE (2001). Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment. American Journal of Psychiatry 158,176-184. (Pubitemid 32116511)
30. Hashimoto K, Fujita Y, Shimizu E, Iyo M (2005). Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of clozapine, but not haloperidol. European Journal of Pharmacology 519, 114-117. (Pubitemid 43181173)
31. Hetem LA, Danion JM, Diemunsch P, Brandt C (2000). Effect of a subanesthetic dose of ketamine on memory and conscious awareness in healthy volunteers. Psychopharmacology (Berlin) 152, 283-288.
32. Honey G, Honey R, Sharar S, Turner D, et al. (2005). Impairment of specific episodic memory processes by sub-psychotic doses of ketamine: the effects of levels of processing at encoding and of the subsequent retrieval task. Psychopharmacology 181, 445-457. (Pubitemid 41480893)
33. Howard AK, Thornton AE, Altman S, Honer WG (2002). Donepezil for memory dysfunction in schizophrenia. Journal of Psychopharmacology 16, 267-270. (Pubitemid 34983084)
34. Javitt DC (2007). Glutamate and schizophrenia: phencyclidine, N-methyl-d-aspartate receptors, and dopamine-glutamate interactions. International Reviews in Neurobiology 78, 69-108.
35. Jentsch JD, Roth RH (1999). The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 20, 201-225. (Pubitemid 29067401)
36. Jentsch JD, Tran A, Le D, Youngren KD, et al. (1997). Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat. Neuropsychopharmacology 17, 92-99. (Pubitemid 127700987)
37. Karasawa J, Hashimoto K, Chaki S (2008). d-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats. Behavioural Brain Research 186, 78-83. (Pubitemid 350100896)
38. Kart-Teke E, De Souza Silva MA, Huston JP, Dere E (2006). Wistar rats show episodic-like memory for unique experiences. Neurobiology of Learning and Memory 85, 173-182. (Pubitemid 43247843)
39. Keefe RSE, Malhotra AK, Meltzer HY, Kane JM, et al. (2007). Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: significant placebo//practice effects in a 12-week, randomized, double-bBlind, placebo-controlled trial. Neuropsychopharmacology 33, 1217-1228.
40. Kumra S, Oberstar J, Sikich L, Findling R, et al. (2008). Efficacy and tolerability of second-generation antipsychotics in children and adolescents with schizophrenia. Schizophrenia Bulletin 34, 60-71. (Pubitemid 350262286)
41. Kunitachi S, Fujita Y, Ishima T, Kohno M, et al. (2009). Phencyclidine-induced cognitive deficits in mice are ameliorated by subsequent subchronic administration of donepezil: role of sigma-1 receptors. Brain Research 1279, 189-196. (Pubitemid 44779614)
42. Lahti A, Koffel B, LaPorte D, Tamminga CA (1995). Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology 13, 9-19.
43. Langston RF, Wood ER (2009). Associative recognition and the hippocampus: differential effects of hippocampal lesions on object-place, object-context and object-place-context memory. Hippocampus. Published online: 21 October 2009. doi:10.1002/hipo.20714.
44. Lee I, Kesner RP (2003). Time-dependent relationship between the dorsal hippocampus and the prefrontal cortex in spatial memory. Journal of Neuroscience 23, 1517-1523. (Pubitemid 36258930)
45. Lee BJ, Lee JG, Kim YH (2007). A 12-week, double-blind, placebo-controlled trial of donepezil as an adjunct to haloperidol for treating cognitive impairments in patients with chronic schizophrenia. Journal ofPsychopharmacology 21, 421-427. (Pubitemid 47077293)
46. Malhotra AK, Pinals DA, Weingartner H, Sirocco K, et al. (1996). NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers. Neuro-psychopharmacology 14, 301-307. (Pubitemid 26151927)
47. Meltzer HY, McGurk SR (1999). The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophrenia Bulletin 25, 233-256.
48. Mitchell RW (1993). Mental models of mirror-self-recognition: two theories. New Ideas in Psychology 11, 295-325.
49. Patil ST, Zhang L, Martenyi F, Lowe SL, et al. (2007). Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial. Nature Medicine 13,1102-1107. (Pubitemid 47517511)
50. Prickaerts J, Sik A, Van Der Staay FJ, De Vente J, et al. (2005). Dissociable effects of acetylcholinesterase inhibitors and phosphodiesterase type 5 inhibitors on object recognition memory: acquisition versus consolidation. Psychopharmacology 177, 381-390. (Pubitemid 40228285)
51. Raedler TJ, Bymaster FP, Tandon R, Copolov D, et al. (2006). Towards a muscarinic hypothesis of schizophrenia. Molecular Psychiatry 12, 232-246. (Pubitemid 46328501)
52. Risch SC, Horner MD, McGurk SR, Palecko S, et al. (2007). Double-blind donepezil-placebo crossover augmentation study of atypical antipsychotics in chronic, stable schizophrenia: a pilot study. Schizophrenia Research 93, 131-135. (Pubitemid 46817923)
53. Riutort M, Cuervo C, Danion JM, Peretti CS, et al. (2003). Reduced levels of specific autobiographical memories in schizophrenia. Psychiatry Research 117, 35-45. (Pubitemid 36173774)
54. Sarter M (2006). Preclinical research into cognition enhancers. Trends in Pharmacological Sciences 27, 602-608. (Pubitemid 44572394)
55. Seillier A, Giuffrida A (2009). Evaluation of NMDA receptor models of schizophrenia: divergences in the behavioral effects of sub-chronic PCP and MK-801. Behavioural Brain Research 204, 410-415.
56. Smith DM (2008). The hippocampus, context processing and episodic memory. In: Handbook of Behavioral Neuroscience, vol.18 (pp. 465-481). Amsterdam, London: Elsevier.
57. Tsuno N (2009). Donepezil in the treatment of patients with Alzheimer's disease. Expert Review ofNeurotherapeutics 9, 591-598.
58. Tugal O, Yazici KM, Anil Yagcioglu AE, Gtigiis A (2004). A double-blind, placebo controlled, cross-over trial of adjunctive donepezil for cognitive impairment in schizophrenia. International Journal of Neuropsychopharmacology 7, 117-123. (Pubitemid 38823278)
59. Tulving E (1983). Elements of Episodic Memory. Oxford: Clarendon Press.
60. Wiley JL (2008). Antipsychotic-induced suppression of locomotion in juvenile, adolescent and adult rats. European Journal of Pharmacology 578, 216-221.
61. Wong AH, Van Tol HH (2003). Schizophrenia: from phenomenology to neurobiology. Neuroscience and Biobehavioral Reviews 27, 269-306.
62. Young JW, Powell SB, Risbrough V, Marston HM, et al. (2009). Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia. Pharmacology & Therapeutics 122, 150-202.